Retour
Fourchette du Jour
28,05 €
29,40 €
Fourchette 52 Semaines
4,81 €
44,89 €
Volume
337 181
Moyenne 50J / 200J
35,10 €
/
22,42 €
Clôture Précédente
27,82 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,2 | 0,2 |
| P/B | 2,6 | 3,0 |
| ROE % | -27,8 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
55,33 €
+91.1%
Low: 18,00 €
High: 88,00 €
BPA Prévisionnel
-2,85 €
CA Est.
0,0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-1,61 €
-1,61 € – -1,61 €
|
256,34M | 5 |
| FY2029 |
-3,09 €
-3,09 € – -3,09 €
|
131,36M | 2 |
| FY2028 |
-4,44 €
-5,85 € – -1,87 €
|
26,51M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-12 | -0,63 € | -0,49 € | +22,2% |
| 2025-11-06 | -0,73 € | -0,63 € | +13,7% |
| 2025-08-07 | -0,77 € | -0,58 € | +24,7% |
| 2025-05-12 | -0,81 € | -0,71 € | +12,3% |
| 2025-03-17 | -0,59 € | -0,47 € | +20,3% |
| 2024-11-07 | -2,72 € | -2,78 € | -2,2% |
| 2024-08-23 | N/A | -11,47 € | — |
| 2023-12-31 | N/A | -0,26 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -81,88M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-27,76%
ROIC-19,89%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio24,62
Interest Coverage0,00
Valorisation
P/E Ratio
-11,19
Forward P/EN/A
P/B Ratio2,63
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -86,97M |
| ROE | -27,76% | ROA | -22,58% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -81,88M |
| ROIC | -19,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 24,62 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -11,19 | Forward P/E | N/A |
| P/B Ratio | 2,63 | P/S Ratio | N/A |
| PEG Ratio | -0,46 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,42% | ||
| Market Cap | 972,86M | Enterprise Value | 898,16M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -86,97M | -61,92M | -32,56M | -26,14M |
| EPS (Diluted) | -2,38 | -1,85 | -1,02 | -0,82 |
| Gross Profit | -248 000,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -98,06M | -68,19M | -35,31M | -25,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 385,14M | 268,54M | 84,18M | 45,10M |
| Total Liabilities | 15,92M | 11,09M | 156,65M | 87,70M |
| Shareholders' Equity | 369,22M | 257,44M | -72,47M | -42,61M |
| Total Debt | 596 000,0 | 171 000,0 | 324 000,0 | 461 000,0 |
| Cash & Equivalents | 75,29M | 49,35M | 30,52M | 24,21M |
| Current Assets | 381,54M | 267,29M | 83,47M | 44,21M |
| Current Liabilities | 15,50M | 11,05M | 3,93M | 3,43M |